Research index
Use of rituximab to decrease panel-reactive antibodies.
Balfour, Fiore, Graff and 1 other
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation1 May 2005
NobleIDark:/48914/w1/20260515/7B8161AADOI10.1016/j.healun.2004.01.006
Use of rituximab to decrease panel-reactive antibodies.
Balfour, Fiore, Graff and 1 other · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2005 · Subscription
NobleIDark:/48914/w1/20260515/7B8161AADOI10.1016/j.healun.2004.01.006
The full text is at the publisher
You can read the abstract here, or open it at the publisher.
Abstract
Patients with pre-formed antibodies may be at increased risk of rejection after organ transplantation. In this report, we describe the use of rituximab to decrease the percentage of pre-formed antibodies in a pediatric heart transplant recipient.